Does IMATINIB Cause Neoplasm malignant? 277 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 277 reports of Neoplasm malignant have been filed in association with IMATINIB (Imatinib). This represents 0.6% of all adverse event reports for IMATINIB.
277
Reports of Neoplasm malignant with IMATINIB
0.6%
of all IMATINIB reports
51
Deaths
38
Hospitalizations
How Dangerous Is Neoplasm malignant From IMATINIB?
Of the 277 reports, 51 (18.4%) resulted in death, 38 (13.7%) required hospitalization, and 6 (2.2%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 277 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which IMATINIB Alternatives Have Lower Neoplasm malignant Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL